These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 23065756)
1. Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells. Do MT; Hwang YP; Kim HG; Na M; Jeong HG J Cell Physiol; 2013 May; 228(5):1087-97. PubMed ID: 23065756 [TBL] [Abstract][Full Text] [Related]
2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
3. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells. Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells. Vazquez-Martin A; Colomer R; Brunet J; Menendez JA Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307 [TBL] [Abstract][Full Text] [Related]
5. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway. Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261 [TBL] [Abstract][Full Text] [Related]
6. Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells. Seo HS; Choi HS; Choi HS; Choi YK; Um JY; Choi I; Shin YC; Ko SG Anticancer Res; 2011 Oct; 31(10):3301-13. PubMed ID: 21965740 [TBL] [Abstract][Full Text] [Related]
7. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Liu W; Furuta E; Shindo K; Watabe M; Xing F; Pandey PR; Okuda H; Pai SK; Murphy LL; Cao D; Mo YY; Kobayashi A; Iiizumi M; Fukuda K; Xia B; Watabe K Breast Cancer Res Treat; 2011 Jul; 128(1):57-68. PubMed ID: 20665104 [TBL] [Abstract][Full Text] [Related]
8. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Do MT; Kim HG; Choi JH; Khanal T; Park BH; Tran TP; Jeong TC; Jeong HG Food Chem; 2013 Dec; 141(3):2591-9. PubMed ID: 23870999 [TBL] [Abstract][Full Text] [Related]
9. Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells. Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Song IS; Kim JR; Chang ES Phytother Res; 2013 May; 27(5):713-20. PubMed ID: 22767439 [TBL] [Abstract][Full Text] [Related]
10. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. Pan MH; Lin CC; Lin JK; Chen WJ J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658 [TBL] [Abstract][Full Text] [Related]
11. Kahweol inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells. Oh SH; Hwang YP; Choi JH; Jin SW; Lee GH; Han EH; Chung YH; Chung YC; Jeong HG Food Chem Toxicol; 2018 Nov; 121():326-335. PubMed ID: 30205135 [TBL] [Abstract][Full Text] [Related]
12. Osthole suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt/mTOR pathway. Lin VC; Chou CH; Lin YC; Lin JN; Yu CC; Tang CH; Lin HY; Way TD J Agric Food Chem; 2010 Apr; 58(8):4786-93. PubMed ID: 20218616 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. Wang J; Xiao X; Zhang Y; Shi D; Chen W; Fu L; Liu L; Xie F; Kang T; Huang W; Deng W J Pineal Res; 2012 Aug; 53(1):77-90. PubMed ID: 22335196 [TBL] [Abstract][Full Text] [Related]
14. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells. Tran TP; Kim HG; Choi JH; Na MK; Jeong HG Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342 [TBL] [Abstract][Full Text] [Related]
15. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577 [TBL] [Abstract][Full Text] [Related]
16. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. Li N; Bu X; Tian X; Wu P; Yang L; Huang P Nutr Cancer; 2012 Aug; 64(6):864-70. PubMed ID: 22860766 [TBL] [Abstract][Full Text] [Related]
17. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1. Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420 [TBL] [Abstract][Full Text] [Related]
18. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification. Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301 [TBL] [Abstract][Full Text] [Related]
19. SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer. Hsueh SP; Hsu WB; Wen CC; Wang WB Cancer Gene Ther; 2011 Dec; 18(12):859-70. PubMed ID: 21869825 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]